The July Stem Cell Evidence Alert is out. See the web version here http://stemcellevidence.com/alerts and sign up to receive your copy, direct to your email, monthly and free of charge
#BMT #StemCellEvidence #leusm #lymsm #mmsm

The Stem Cell Evidence Alert is out! Check your inbox or see a web version here: https://tinyurl.com/3dc454c3 Sign up FREE at www.stemcellevidence.com/alerts
#BMT #StemCellEvidence

The Stem Cell Evidence Alert is out! Check your inbox or see the web version here https://bit.ly/41Jl1CX Sign up FREE at http://stemcellevidence.com/alerts to receive future editions in your inbox
#BMT #StemCellEvidence

The March #StemCellEvidence Alert is out! If you don't receive it free in your inbox, sign up and see this month's top ten references here: http://www.stemcellevidence.com/alerts
#BMT #leusm #mmsm #lymsm

Our group's impact in 2022 #StemCellEvidence #Transfusion #Evidence

Our group's impact in 2022 #StemCellEvidence #Transfusion #Evidence

T-replete #cord transplants give superior outcomes in high risk and relapsed/refractory paediatric myeloid malignancy Our top article this month in the #StemCellEvidence Alert by Claire Horgan et al in @BloodAdvances
stemcellevidence.com/article/366495…
#leusm #BMT

The Stem Cell Evidence Alert is out! Check your inbox or visit http://www.stemcellevidence.com/alerts to see our top ten and sign up FREE
#BMT #StemCellEvidence

From our Evidence Alert this month: Stem cell mobilization yields with daratumumab and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma Chhabra et al in Transplantation and Cellular Therapy http://www.stemcellevidence.com/article/36494017
#BMT #mmsm #StemCellEvidence

Our top article this month is Hermine et al in @JCO_ASCO High-Dose Cytarabine and AutoHSCTin Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial. http://www.stemcellevidence.com/article/36469833 #BMT #StemCellEvidence
#BMT #lymsm #StemCellEvidence